United StatesHealthcare and life sciences2020 – ongoingAbbVie
ARCH research knowledge platform
AbbVie connected research data with NLP-derived biomedical relationships to investigate drug repurposing
Problem
AbbVie researchers worked with disconnected internal datasets and external scientific information. Combining those sources required normalization and shared definitions.
Approach
AbbVie began building ARCH in 2020 with partners including Modak, SciBite and Tellic. The platform combined biomedical relationships extracted through NLP with internal research data in a knowledge graph. Researchers used computational workspaces to explore the data and share applications across R&D.
Results
No published figures
Takeaway
AbbVie paired research-data integration with tools scientists could use to build their own applications. Reported drug-repurposing findings did not establish clinical benefits for patients.
Categories
- Size
- Large enterprise
- Industry
- Healthcare and life sciences
- Business function
- IT and R&DInternal work and knowledge management
- Innovation type
- Process innovation
- AI technology
- Predictive analytics and ML
- Adoption
- Partner co-development
- Evidence
- Company's own claim
Sources
Source summaries
Bio-IT World reported AbbVie research leader Brian Martin's account of ARCH's construction and use. Martin described NLP-derived knowledge integration and pointed to research on possible drug repurposing published in December 2022.
Full details are in the original sources.